- Home
- NSTS vs TVGN Comparison
NSTS vs TVGN Comparison
Compare NSTS & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NSTS | TVGN |
|---|---|---|
| Founded | 1921 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Blank Checks |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.8M | 63.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | NSTS | TVGN |
|---|---|---|
| Price | $12.65 | $6.71 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.7K | ★ 19.4K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $252,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.73 | $0.14 |
| 52 Week High | $13.06 | $10.76 |
Technical Indicators
Market Signals| Indicator | NSTS | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 60.79 | 53.64 |
| Support Level | $12.52 | $0.47 |
| Resistance Level | $12.74 | $9.40 |
| Average True Range (ATR) | 0.30 | 0.82 |
| MACD | 0.05 | -0.18 |
| Stochastic Oscillator | 73.70 | 26.02 |
Price Performance
Historical ComparisonAbout NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.